The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 13,001–13,100 of 31,469
Metabolically Healthy Obesity Is Not Associated with Food Intake in White or Black Men
Kimokoti, R. W., Judd, S. E., Shikany, J. M., & Newby, P. K. (2015) · Journal of Nutrition · doi:10.3945/jn.115.221283 · Cited by 27
Wójcik, M., Zieleniak, A., Żurawska-Kliś, M., Cypryk, K., & Woźniak, L. A. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215615699 · Cited by 26
Sentinelli, F., Bertoccini, L., Barchetta, I., Capoccia, D., Incani, M., Pani, M. G., Loche, S., Angelico, F., Arca, M., Morini, S., et al. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.02.004 · Cited by 27
de Almeida-Pititto, B., Ribeiro‐Filho, F. F., Bittencourt, M. S., Lotufo, P. A., Benseñor, I. M., & Ferreira, S. R. G. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0133-9 · Cited by 26
Perticone, M., Cimellaro, A., Maio, R., Caroleo, B., Sciacqua, A., Sesti, G., & Perticone, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040456 · Cited by 26
Metabolic syndrome in infertile women with polycystic ovarian syndrome
Madani, T., Hosseini, R., Ramezanali, F., Khalili, G., Jahangiri, N., Ahmadi, J., Rastegar, F., & Zolfaghari, Z. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000135 · Cited by 27
Brader, L., Overgaard, A., Christensen, L. P., Jeppesen, P., & Hermansen, K. (2013) · The review of diabetic studies : RDS · doi:10.1900/rds.2013.10.270 · Cited by 31
Postmenopausal hypertension, abdominal obesity, apolipoprotein and insulin resistance
Ali, S. B., Belfki, H., Ahmed, D. B., Haddad, N., Jmal, A., Abdennebi, M., & Romdhane, H. B. (2016) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2015.1131286 · Cited by 27
Zheng, J., Xiao, X., Zhang, Q., Yu, M., Xu, J., Qi, C., & Wang, T. (2016) · Bioscience Reports · doi:10.1042/bsr20160103 · Cited by 26
Kim, J., Lee, S. K., Shin, J., Jeoun, U., Jang, Y. J., Park, H. S., Kim, J.-H., Gong, G., Lee, T. J., Hong, J. P., et al. (2016) · Scientific Reports · doi:10.1038/srep30609 · Cited by 27
Ye, D., Yang, F., Ling, Q., Xu, W., Zhang, Z., Shu, J., Li, C., & Dong, F. (2016) · Scientific Reports · doi:10.1038/srep30686 · Cited by 26
Kahl, K. G., Herrmann, J., Stubbs, B., Krüger, T. H. C., Cordes, J., Deuschle, M., Schweiger, U., Hüper, K., Helm, S., Birkenstock, A., et al. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.08.005 · Cited by 27
Ahn, N., & Kim, K. (2016) · Journal of Physical Therapy Science · doi:10.1589/jpts.28.2227 · Cited by 26
Effect of supramaximal exercise training on metabolic outcomes in obese adults
Jabbour, G., Mauriège, P., Joanisse, D. R., & Iancu, H.-D. (2016) · Journal of Sports Sciences · doi:10.1080/02640414.2016.1243798 · Cited by 26
Lee, D., Chun, E. J., Hur, J. H., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.12.011 · Cited by 26
Xia, H., Zhang, R., Sun, X., Wang, L., & Zhang, W. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12957 · Cited by 27
Sohrevardi, S. M., Nosouhi, F., Khalilzade, S. H., Kafaie, P., Karimi‐Zarchi, M., Halvaei, I., & Mohsenzadeh, M. (2016) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.29252/ijrm.14.12.743 · Cited by 26
de Queiroz, K. B., Sampaio, K. H., Rossoni, J. V., Leal, D. A., Pinto, A. B. G., Becker, L. K., Evangelista, E. A., & Guerra‐Sá, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172103 · Cited by 26
Mudi, S. R., Akhter, M., Biswas, S. K., Muttalib, M. A., Choudhury, S., Rokeya, B., & Ali, L. (2017) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2016-0111 · Cited by 27
Nguyen, K. A., Peer, N., de Villiers, A., Mukasa, B., Matsha, T. E., Mills, E. J., & Kengne, A. P. (2017) · International Journal of Endocrinology · doi:10.1155/2017/1613657 · Cited by 26
Maxel, T., Svendsen, P. F., Smidt, K., et al. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00038 · Cited by 26
Kitaoka, K., Takeuchi, M., Tsuboi, A., Minato, S., Kurata, M., Tanaka, S., Kazumi, T., & Fukuo, K. (2017) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0011 · Cited by 26
Kunutsor, S. K., Kieneker, L. M., Bakker, S. J. L., James, R. W., & Dullaart, R. P. F. (2017) · Metabolism · doi:10.1016/j.metabol.2017.05.004 · Cited by 26
Hübers, M., Geisler, C., Plachta‐Danielzik, S., & Müller, M. J. (2017) · Nutrition and Diabetes · doi:10.1038/nutd.2017.20 · Cited by 26
Motta, V. F., Bargut, T. C. L., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00154.2017 · Cited by 27
Kunutsor, S. K., Kieneker, L. M., Bakker, S. J. L., James, R. W., & Dullaart, R. P. F. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.06.353 · Cited by 26
Boccara, F., Ghislain, M., Meyer, L., Goujard, C., May, C. L., Vigouroux, C., Bastard, J. P., Fellahi, S., Capeau, J., Cohen, A. A., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001633 · Cited by 26
Keerthi, G. S. (2017) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2017/29307.10633 · Cited by 26
Heidari, Z., Abdani, M., & Mansournia, M. A. (2017) · Intern J Endocrinol Metab · doi:10.5812/ijem.14545 · Cited by 26
Monzani, A., Perrone, M., Prodam, F., Moia, S., Genoni, G., Testa, S., Paglialonga, F., Rapa, A., Bona, G., Montini, G., et al. (2017) · Pediatric Nephrology · doi:10.1007/s00467-017-3840-z · Cited by 28
Bequer, L., Gómez, T., Molina, J. L., et al. (2017) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2017.1395928 · Cited by 26
Lai, Y., & Sun, C. (2017) · Oncology Letters · doi:10.3892/ol.2017.7590 · Cited by 26
Early Markers of Cardiovascular Risk in Autosomal Dominant Polycystic Kidney Disease
Lai, S., Mastroluca, D., Matino, S., Panebianco, V., Vitarelli, A., Capotosto, L., Turinese, I., Marinelli, P., Rossetti, M., Galani, A., et al. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000486011 · Cited by 26
Inoue, K., Yoshiuchi, S., Yoshida, M., Nakamura, N., Nakajima, S., Kitamura, A., Mouri, K., Michiura, T., Mukaide, H., Ozaki, T., et al. (2018) · Asian Journal of Endoscopic Surgery · doi:10.1111/ases.12479 · Cited by 26
miR199a-5p inhibits hepatic insulin sensitivity via suppression of ATG14-mediated autophagy
Li, B., Wu, X., Chen, H., Zhuang, C., Zhang, Z., Yao, S., Cai, D., Ning, G., & Su, Q. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0439-7 · Cited by 26
Ekblad, L. L., Toppala, S., Johansson, J. K., Koskinen, S. V. P., Sundvall, J., Rinne, J. O., Puukka, P. J., Viitanen, M. H., & Jula, A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170972 · Cited by 27
Wang, L. X., Filipp, S. L., Urbina, E. M., Gurka, M. J., & DeBoer, M. D. (2018) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0160 · Cited by 28
Pinnaduwage, L., Ye, C., Hanley, A. J., Connelly, P. W., Sermer, M., Zinman, B., & Retnakaran, R. R. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00306 · Cited by 26
Sîrbu, A. M., Buburuzan, L., Kevorkian, S., Martin, S. C., Barbu, C. G., Copăescu, C., Smeu, B., & Fica, S. V. (2018) · Endokrynologia Polska · doi:10.5603/ep.a2018.0026 · Cited by 27
Metabolic Syndrome and Its Components in Young Adults Conceived by ICSI
Belva, F., Bonduelle, M., Provyn, S., et al. (2018) · International Journal of Endocrinology · doi:10.1155/2018/8170518 · Cited by 26
Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats
Eshaghian‐dorcheh, A., Khodarahmi, A., Safari, F., Binesh, F., & Moradi, A. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114518001095 · Cited by 26
Wang, C., Yu, T., Shih, S., Huang, K., & Chang, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-29087-1 · Cited by 26
The relationship of maternal glycemia to childhood obesity and metabolic dysfunction‡
Landon, M. B., Mele, L., Varner, M. W., Casey, B. M., Reddy, U. M., Wapner, R. J., Rouse, D. J., Tita, A., Thorp, J. M., Chien, E. K., et al. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1484094 · Cited by 26
Alkhudhairy, F., Vohra, F., Kheraif, A. A. A., & Akram, Z. (2018) · Clinical Implant Dentistry and Related Research · doi:10.1111/cid.12633 · Cited by 30
Tarantino, G., Costantini, S., Citro, V., Conforti, P., Capone, F., Sorice, A., & Capone, D. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-018-1754-6 · Cited by 26
Wekker, V., Huvinen, E., van Dammen, L., Rönö, K., Painter, R. C., Zwinderman, A. H., van de Beek, C., Sarkola, T., Mol, B. W., Groen, H., et al. (2018) · European Journal of Public Health · doi:10.1093/eurpub/cky222 · Cited by 28
Kim, S.-H., On, J., Pyo, H., Ko, K. S., Won, J. C., Yang, J.-Y., & Park, M. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208081 · Cited by 26
Darlow, B. A., Martin, J., & Horwood, L. J. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.10.060 · Cited by 27
Yoon, J.-R., Ha, G.-C., Ko, K.-J., & Kang, S.-J. (2018) · Journal of Exercise Rehabilitation · doi:10.12965/jer.1836446.223 · Cited by 26
Yi, Y. H., Cho, Y. H., Kim, Y. J., et al. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s185604 · Cited by 26
Adipose Tissue CTGF Expression is Associated with Adiposity and Insulin Resistance in Humans
Yoshino, J., Patterson, B. W., & Klein, S. (2019) · Obesity · doi:10.1002/oby.22463 · Cited by 29
Bastien, M., Poirier, P., Brassard, P., Arsenault, B. J., Bertrand, O. F., Després, J., Costerousse, O., & Piché, M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00505.2018 · Cited by 26
VUONO, S. D., Ricci, M. A., Migliola, E. N., Monti, M. C., Morretta, E., Boni, M., Ministrini, S., Carino, A., Fiorucci, S., Distrutti, E., et al. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03877-6 · Cited by 25
Anchuelo, A. C., Martínez-Larrad, M. T., Serrano‐García, I., Fernández, C., & Serrano‐Ríos, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216877 · Cited by 29
Aranaz, P., Romo‐Hualde, A., Navarro‐Herrera, D., Zabala, M., Lópeź‐Yoldi, M., González-Ferrero, C., Gil, A. G., Martínez, J. A., Vizmanos, J. L., Milagro, F. I., et al. (2019) · Food & Function · doi:10.1039/c9fo00918c · Cited by 26
High-fat diet intake induces depressive-like behavior in ovariectomized rats
Boldarine, V. T., Pedroso, A. P., Neto, N. I. P., Dornellas, A. P. S., do Nascimento, C. M. O., Oyama, L. M., & Ribeiro, E. B. (2019) · Scientific Reports · doi:10.1038/s41598-019-47152-1 · Cited by 27
Sympathetic Nerve Traffic and Arterial Baroreflex Function in Apparent Drug-Resistant Hypertension
Dell’Oro, R., Quarti‐Trevano, F., Seravalle, G., Zanchettin, F., Bertoli, S. V., Airoldi, F., Mancia, G., & Grassi, G. M. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13009 · Cited by 26
Gao, R., DUFF, W. R. D., Chizen, D. R., Zello, G. A., & Chilibeck, P. D. (2019) · Nutrients · doi:10.3390/nu11092012 · Cited by 26
Farias, G., Netto, B. D. M., Boritza, K. C., Bettini, S. C., Vilela, R. M., & Dâmaso, A. R. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04411-9 · Cited by 26
Du, J., He, W., Zhang, C., Wu, J., Li, Z., Wang, M., Feng, S., & Liang, G. (2020) · BioMed Research International · doi:10.1155/2020/3243906 · Cited by 25
Arsenic Exposure Decreases Adiposity During High‐Fat Feeding
Carmean, C. M., Kirkley, A. G., Landeche, M., Ye, H., Chellan, B., Aldirawi, H., Roberts, A. A., Parsons, P. J., & Sargis, R. M. (2020) · Obesity · doi:10.1002/oby.22770 · Cited by 27
Lycopene-supplemented diet ameliorates metabolic syndrome induced by fructose in rats
Ferreira‐Santos, P., Aparicio, R., Carrón, R., Montero, M. J., & Sevilla, M. A. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104098 · Cited by 26
Sobhana, P. P., Kandlakunta, B., Nagaraju, R., Thappatla, D., Epparapalli, S., Vemula, S. R., Gavaravarapu, S. R. M., & Korrapati, D. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13465 · Cited by 29
Lv, X., Fang, K., Hao, W., Han, Y., Yang, N., & Yu, Q. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s280084 · Cited by 27
Su, C., Wang, K., Hsia, T., Chen, C.-S., & Tung, T. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200607000-00015 · Cited by 26
Petta, S., Cammà, C., Marco, V. D., Calvaruso, V., Enea, M., Bronte, F., Butera, G., Cabibi, D., & Craxı̀, A. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04079.x · Cited by 26
Genetic factors play an important role in the pathogenesis of hyperlipidemia post-transplantation
Aguilar-Salinas, C. A., Díaz-Polanco, A., Quintana, E., et al. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.33926 · Cited by 26
Ang, M., Müller, A. S., Wagenlehner, F. R. A., Pilatz, A. M. E., & Linn, T. (2012) · Metabolism · doi:10.1016/j.metabol.2012.05.008 · Cited by 29
Capoulade, R., Côté, N., Mathieu, P., Chan, K. L., Clavel, M.-A. A., Dumesnil, J. G., Teo, K. K., Tam, J. W., Fournier, D., Després, J., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.03.025 · Cited by 27
Hays, N. P., Starling, R. D., Sullivan, D. H., et al. (2006) · Metabolism · doi:10.1016/j.metabol.2005.11.005 · Cited by 26
Derosa, G., Cicero, A. F. G., D’Angelo, A., et al. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.03.015 · Cited by 26
Relationship between basal metabolic rate and cortisol secretion throughout pregnancy
Damjanovic, S. S., Stojic, R. V., Lalic, N. M., Jotić, A., Μacut, D., Ognjanovic, S. I., Petakov, M. S., & Popovic, B. M. (2009) · Endocrine · doi:10.1007/s12020-008-9137-z · Cited by 25
Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population
Yamada, A., Shoji, T., Tahara, H., Emoto, M., & Nishizawà, Y. (2001) · Metabolism · doi:10.1053/meta.2001.24215 · Cited by 26
Rendo‐Urteaga, T., Puchau, B., Chueca, M., Oyarzabal, M., Azcona, C., Martínez, J. A., & Martí, A. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-013-2229-7 · Cited by 26
Solano, M. P., PERRY, A. C., Wang, X., Ross, R., & Goldberg, R. B. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802192 · Cited by 26
Association between Impaired Insulin Sensitivity and Stroke
Bravata, D. M., Wells, C. K., Kernan, W. N., Concato, J., Brass, L. M., & Gulanski, B. (2005) · Neuroepidemiology · doi:10.1159/000086286 · Cited by 26
Sleeve Gastrectomy With or Without a Multimodal Perioperative Care. A Randomized Pilot Study
Pimenta, G. P., Capellan, D., & de Aguilar‐Nascimento, J. E. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1573-2 · Cited by 27
Lipolysis and Insulin Sensitivity at Birth in Infants Who Are Large for Gestational Age
Ahlsson, F., Diderholm, B., Ewald, U., et al. (2007) · PEDIATRICS · doi:10.1542/peds.2007-0165 · Cited by 26
Effects of exercise intensity and duration on fat metabolism in trained and untrained older males
Bassami, M., Ahmadizad, S., Doran, D. A., & MacLaren, D. P. M. (2007) · European Journal of Applied Physiology · doi:10.1007/s00421-007-0523-7 · Cited by 26
Evidence for Increased Risk of Prediabetes in the Uremic Patient
Shehab-Eldin, W. A., Ragheb, A., Klassen, J., & SHOKER, A. S. (2007) · Nephron Clinical Practice · doi:10.1159/000112529 · Cited by 26
Hwu, C., Hsiao, C., Kuo, S., et al. (2004) · Blood Pressure · doi:10.1080/08037050410004828 · Cited by 26
Peripartum maternal and foetal ghrelin, growth hormones, IGFs and insulin interrelations
Fuglsang, J., Sandager, P., Møller, N., Fisker, S., Frystyk, J., & Ovesen, P. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02498.x · Cited by 26
Stolinski, M., Alam, S., Jackson, N. C., Shojaee‐Moradie, F., Pentecost, C., Jefferson, W., Christ, E., Jones, R. H., & Umpleby, A. M. (2008) · Metabolism · doi:10.1016/j.metabol.2008.06.018 · Cited by 26
Fontán, M. P., Cordido, F., Rodríguez–Carmona, A., Penin, M., Cambre, H. D., Lopez-Muniz, A., Sangiao‐Alvarellos, S., & García‐Buela, J. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn297 · Cited by 26
Serum cholesteryl fatty acid composition and plasma glucose concentrations in Amerindian women
Lindgärde, F., Vessby, B. O., & Åhrén, B. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.5.1009 · Cited by 26
Anastasiou, C. A., Yannakoulia, M., Pirogianni, V., Rapti, G., Sidossis, L. S., & Kavouras, S. A. (2010) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2009.10.040 · Cited by 26
Choi, E. Y., Park, E. H., Cheong, Y. S., Rheem, I., Park, S. G., & Yoo, S. (2006) · Metabolism · doi:10.1016/j.metabol.2005.11.002 · Cited by 26
Bouchard, L., Vohl, M., Deshaies, Y., Rhéaume, C., Daris, M., & Tchernof, A. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0073 · Cited by 26
Chala, E., Manes, C., Iliades, H., et al. (2006) · HORMONES · doi:10.14310/horm.2002.11177 · Cited by 26
Panidis, D., Τζιόμαλος, Κ., Koiou, E., Kandaraki, E., Tsourdi, E. A., Delkos, D., Kalaitzakis, E., & Katsikis, I. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-151 · Cited by 26
Tosi, F., Sarra, D. D., Bonin, C., Zambotti, F., Dall'Alda, M., Fiers, T., Kaufman, J., Donati, M., Franchi, M. P., Zanolin, M. E., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0761 · Cited by 26
Insulinogenic index at 15 min as a marker of nutritional rehabilitation in anorexia nervosa
Yasuhara, D., Naruo, T., Nagai, N., Tanaka, M., Muranaga, T., & Nozoe, S.-I. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.2.292 · Cited by 26
Distribuição da gordura corporal e perfis lipídico e glicêmico de pacientes infectados pelo HIV
Guimarães, M. M. M., Greco, D. B., Júnior, A. R. D. O., Penido, M. G., & Machado, L. J. D. C. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000100008 · Cited by 26
Vanithadevi, B., & Anuradha, C. V. (2019) · International Journal of Diabetes and Metabolism · doi:10.1159/000497651 · Cited by 26
Falasca, K., Manigrasso, M. R., Racciatti, D., Zingariello, P., Dalessandro, M., Ucciferri, C., Mancino, P., Marinopiccoli, M., Petrarca, C., Conti, P., et al. (2006) · PubMed · Cited by 26
Bando, Y., Ushiogi, Y., Okafuji, K., et al. (1999) · Journal of International Medical Research · doi:10.1177/030006059902700201 · Cited by 26
Stelmachowska‐Banaś, M., Zdunowski, P., & Zgliczyński, W. (2009) · PubMed · Cited by 26
Adiponectin But Not Resistin Is Associated with Insulin Resistance‐Related Phenotypes in Baboons
Tejero, M. E., FREELAND-GRAVES, J. H., Proffitt, J. M., Peebles, K. W., Cai, G., Cole, S. A., & Comuzzie, A. G. (2004) · Obesity Research · doi:10.1038/oby.2004.105 · Cited by 26
Pharmacologic Therapies for Acromegaly
Pereira, A. M., Biermasz, N. R., Roelfsema, F., & Romijn, J. A. (2005) · Treatments in Endocrinology · doi:10.2165/00024677-200504010-00005 · Cited by 26
Hypoglycemia and pulmonary edema: a forgotten association.
Ortega, E., Wägner, A. M., Caixàs, A., Barcons, M., & Corcoy, R. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.1023 · Cited by 26
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
